Fig. 2From: Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumorsClinical course of case 2, 47-year-old female, corticotroph cell adenoma. Entecavir was administered 22 days before transsphenoidal surgery and discontinued 2 years after the surgery. HBV-DNA level was temporary increased after the surgery, and immediately decreased to lower detection sensitivity. Steroid coverage was discontinued 3 days after the surgeryBack to article page